Tradestie Institutional Equity Comparison Engine

ADPT vs ATYR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (2โ€“1 Pillars ยท 3โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Growth & Margin, Momentum & Technical while ADPT counters with relative strength in Options & Structure. Fundamentally, ADPT trades at N/M Forward P/E with -16.2% operating margin (-10.7% YoY revenue) versus ATYR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ADPT sits in BREAKOUT (36th %ile IV; Dealer Gamma Walls on Pro) against ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ADPT N/M vs ATYR N/M Fwd P/E
Growth & Margin Winner ATYR
Op Margin -16.2% vs 0.0% ยท YoY -10.7% vs +0.0%
Momentum & Technical Winner ATYR
1Y +101.8% vs +541.4% ยท 52W Pos 81% vs 60%
Options & Structure Winner ADPT
BREAKOUT (36th %ile IV) vs UNCLASSIFIED (36th %ile IV)
ADPT NASDAQ
Adaptive Biotechnologies Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$28.46
+2.12% 1D
Market Cap $4.7B
1M Return +18.83%
1Y Return +101.84%
Forward P/E N/M
Unified AI Score
43.2 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.83
-7.82% 1D
Market Cap $15.6M
1M Return +2713.05%
1Y Return +541.43%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADPT +101.84% ATYR +541.43% Spread: +439.59 pp (ATYR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ADPT Revenue ATYR Revenue ADPT Op. Margin ATYR Op. Margin Margin Edge
FY2018 $60M N/A -89.4% N/A ADPT
FY2019 $90M $0M -92.1% -5445.0% ADPT
FY2020 $100M $10M -155.3% -152.2% ATYR
FY2021 $150M N/A -135.4% N/A ADPT
FY2022 $190M $10M -108.0% -446.8% ADPT
FY2023 $170M $0M -133.3% -15557.8% ADPT
FY2024 $180M $0M -90.8% -28899.6% ADPT
FY2025 $280M $0M -20.6% -40856.3% ADPT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADPT (5) vs ATYR (3)
Institutional Metric ADPT ATYR Criterion Row Winner
Market Capitalization Scale $4.7B $15.6M Larger Scale ADPT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -10.7% +0.0% Higher Growth ATYR
Operating Margin (TTM) Profitability -16.2% 0.0% Higher Margin ATYR
Net Profit Margin Profitability -23.7% 0.0% Higher Margin ATYR
Return on Equity (ROE) Capital Efficiency -36.4% -93.7% Higher ROE ADPT
52-Week Range Position Momentum 81% ($12โ€“$32) 60% ($0โ€“$8) Stronger Trend ADPT
Beta / 30D Volatility Risk Regime 1.71ฮฒ ยท 59% Vol -9.57ฮฒ ยท 13806% Vol Lower Realized Risk ADPT
Unified Institutional Score Composite Signal 43.2 / 100 (HOLD) 34.3 / 100 (SELL) Higher Composite ADPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADPT vs ATYR Buy Guide
ADPT BREAKOUT
70d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ADPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADPT nor ATYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.